We fight to change economic policy and narratives in order to build public power, break up concentrations of private power, and deliver true opportunity and prosperity for all.
Watch VideoAfter decades of deregulation and complacency, the time is ripe to embark on a grand national project to fundamentally rethink how energy is generated and distributed in the U.S.
Many go-to summertime staples — including ground beef, popsicles, and potato salad — are up more than 20% in just one year, nearly five times the overall inflation rate.
One year after the passage of the so-called One Big Beautiful Bill Act (OBBBA), families across the country are still grappling with a cost of living crisis exacerbated by President Trump’s economic agenda.
Americans pay more for prescription drugs than patients in any other wealthy country, and it's not just due to exorbitant pricing by drug manufacturers. Three corporate middlemen — CVS Caremark, Express Scripts, and OptumRx — control key channels in the drug supply chain, including roughly 80% of prescription claims in the U.S. Their business model artificially inflates and benefits from high drug prices. Government regulation and enforcement is not enough.
The U.S. pharmaceutical industry is a highly profitable, highly extractive industry. While it delivers scientific breakthroughs and develops life-saving treatments for illnesses that were once incurable, the industry fails Americans on numerous fronts. We lack a business model that can discipline or provide an alternative to the price gouging rampant in both branded and generic drug markets. In this brief, we propose a solution: AmericaRx.
From health care to travel to energy, Trump’s corrupt wheelings and dealings have drained money from American families.
As Trump’s war in Iran sends gas prices soaring, major oil companies are cashing in.
As Americans kick off the summer this Memorial Day weekend, Trump’s mishandling of the economy will leave families paying much more to enjoy the warmer season.
As extreme heat intensifies, the cost of inaction will be measured in lives lost. The question facing policymakers is no longer whether effective protections exist, but whether they have the political will to stand up to those unscrupulous employers lobbying hard to block them.
Nearly a year after Trump signed the One Big Beautiful Bill, families are paying more, earning less, and losing the benefits they depend on.
